Immunology Physician Scientist

描述（由申请人提供）：这是NIH T32机构培训补助金的新申请，用于在北岸LIJ卫生系统内的Feinstein医学研究所培训免疫介导性疾病研究的内科科学家。大量的申请者（过敏和免疫学住院医师培训计划每年约110人）是培养免疫学领域研究人员的优秀医生候选人的来源。这些候选人将通过竞争被任命为T32培训计划的3年严格的科学培训。16位已成立的范斯坦学院调查人员经过精心挑选，根据他们在研究和教学方面的卓越表现担任导师。受训者将在Feinstein研究所的Elmezzi研究生院注册课程，以获得免疫学、遗传学和基因组学方面的全面知识，以及临床和转化研究原则。他们将在编写和出版稿件、在国家会议上作口头报告、编写赠款申请等方面接受指导，并将在发展调查事业方面得到协助。范斯坦研究所提供了一个高度互动的研究人员的关键质量，包括Elmezzi学校的研究生，医学院的学生（纽约大学阿尔伯特·爱因斯坦医学院），博士研究员和医学博士/博士研究员。导师将提供3个主题领域的培训机会：1)自身免疫和免疫反应；2)遗传和疾病发病机制；3)炎症和宿主对感染的反应。这些导师在临床和转化研究中提供了对免疫介导疾病的深入和多样化的接触。该T32培训计划的目标是培养免疫学内科科学家，他们将成为未来的研究者领导者，吸引和维持代表性不足的少数民族，并解决全国对免疫学研究者的需求。它的独特性是承诺和成功的转变临床实践的特点导师。

DESCRIPTION (provided by applicant): This is a new application for a NIH T32 institutional training grant for training Physician-Scientists in research in immune-mediated disease at The Feinstein Institute for Medical Research within the North Shore LIJ Health System. The large applicant pool (>110 per year for the Allergy and Immunology Residency Training Program) is a source of outstanding physician candidates to train as investigators in the discipline of immunology. These candidates will be competitively selected for appointment to the T32 training program for 3 years of rigorous scientific training. Sixteen established Feinstein faculty investigators have been carefully selected to serve as mentors, based on their excellence in research and teaching. Trainees will enroll in courses at the Elmezzi Graduate School at the Feinstein Institute to acquire a comprehensive fund of knowledge in immunology, genetics and genomics, and the principles of clinical and translational research. They will receive instruction in the preparation and publication of manuscripts, oral presentations at national meetings, preparation of grant applications, and will be assisted in the development of an investigative career. The Feinstein Institute provides a highly interactive critical mass of investigators with diverse trainees comprised of graduate students in the Elmezzi School, medical students (Albert Einstein College of Medicine, NYU), PhD fellows and MD/PhD fellows. Mentors will provide training opportunities in 3 thematic areas: 1) autoimmunity and immune responsiveness, 2) genetic and disease pathogenesis, and 3) inflammation and host response to infection. These mentors provide an in depth and diverse exposure to immune-mediated diseases at the bench in clinical and translational studies. The goal of this T32 training program is to develop immunology physician-scientists who will serve as future investigator leaders, attract and maintain underrepresented minorities, and address the national need for immunology investigators. Its uniqueness is the commitment to and success at transforming clinical practice that characterizes the mentors. RELEVANCE: The decline in physician-scientists is a serious concern. Highly trained individuals completing training programs in immunology are needed to maintain the rapid pace of novel and creative advances in biomedical research that enhance the care of patients with immunologic and inflammatory disorders. These disorders, in aggregate affect over 150 million individuals in the U.S. alone, at a cost of over $100 billion annually. This new training program is committed to successfully respond to this important challenge.